Fisher P B, Young C S, Weinstein I B, Carter T H
Department of Microbiology, Columbia University College of Physicians and Surgeons, New York, New York 10032.
Mol Cell Biol. 1981 Apr;1(4):370-80. doi: 10.1128/mcb.1.4.370-380.1981.
In this study we evaluated the effect of phorbol ester tumor promoters on the kinetics of adenovirus type 5 (Ad5) replication in human cells. When added at the time of infection, 12-O-tetradecanoyl-phorbol-13-acetate (TPA) accelerated the appearance of an early virus antigen (72,000-molecular-weight [72K] deoxyribonucleic acid-binding protein), the onset of viral deoxyribonucleic acid synthesis, and the production of infectious virus. The appearance of an Ad5-specific cytopathic effect (CPE) was also accelerated in infected cultures exposed to TPA, whereas phorbol, 4 alpha-phorbol-12,13-didecanoate and 4-OmeTPA, which are inactive as tumor promoters, were ineffective in inducing this morphological change. The acceleration of the CPE seen in TPA-treated Ad5-infected cells was not caused by TPA induction of the protease plasminogen activator, since the protease inhibitors leupeptin and antipain do not inhibit the earlier onset of this CPE and, in contrast, epidermal growth factor, which induces plasminogen activator in HeLa cells, does not induce an earlier CPE. Evidence for a direct effect of TPA on viral gene expression was obtained by analyzing viral messenger ribonucleic acid (mRNA) synthesis. TPA accelerated the appearance of mRNA from all major early regions of Ad5, transiently stimulated the accumulation of region III mRNA, and accelerated the appearance of late Ad5 mRNA. Thus, TPA altered the temporal program of Ad5 mRNA production and accelerated the appearance of at least some Ad5-specific polypeptides during lytic infection of human cells. These effects presumably explain the earlier onset of the Ad5-specific CPE in TPA-treated cells and may have relevance to the effects of TPA on viral gene expression in nonpermissive cells carrying integrated viral deoxyribonucleic acid sequences.
在本研究中,我们评估了佛波酯肿瘤启动子对人细胞中5型腺病毒(Ad5)复制动力学的影响。在感染时添加12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA),可加速早期病毒抗原(72,000分子量[72K]脱氧核糖核酸结合蛋白)的出现、病毒脱氧核糖核酸合成的起始以及感染性病毒的产生。在暴露于TPA的感染培养物中,Ad5特异性细胞病变效应(CPE)的出现也加快了,而作为肿瘤启动子无活性的佛波醇、4α - 佛波醇 - 12,13 - 二癸酸酯和4 - OmeTPA在诱导这种形态变化方面无效。TPA处理的Ad5感染细胞中CPE的加速并非由TPA诱导蛋白酶纤溶酶原激活剂所致,因为蛋白酶抑制剂亮抑酶肽和抗蛋白酶不抑制这种CPE的较早出现,相反,在HeLa细胞中诱导纤溶酶原激活剂的表皮生长因子不会诱导更早的CPE。通过分析病毒信使核糖核酸(mRNA)合成获得了TPA对病毒基因表达直接作用的证据。TPA加速了Ad5所有主要早期区域mRNA的出现,短暂刺激了区域III mRNA的积累,并加速了Ad5晚期mRNA的出现。因此,TPA改变了Ad5 mRNA产生的时间程序,并在人细胞的裂解感染过程中加速了至少一些Ad5特异性多肽的出现。这些效应可能解释了TPA处理细胞中Ad5特异性CPE的较早出现,并且可能与TPA对携带整合病毒脱氧核糖核酸序列的非允许细胞中病毒基因表达的影响有关。